Searched for
THIERRY VOLLE
Lupin's arm gets UK regulator nod for COPD treatmentGlobal pharma major Lupin Limited on Friday announced that its UK subsidiary, Lupin Healthcare (UK) Limited, has received approval from the...26 Aug, 2022, 03.28 PM IST- Lupin enters pact with Medis to distribute orphan drug in EuropeNDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following vol...09 Feb, 2022, 07.32 PM IST
- Lupin inks distribution pact with 3 firms to commercialise NaMuscla in EuropeExeltis Healthcare SL, Cresco Pharma BV and Macure Pharma ApS will commercialise NaMuscla for the symptomatic treatment of myotonia in adul...03 Jun, 2020, 01.18 PM IST
- Buy Lupin Ltd. target Rs 1470.0 : Sumeet BagadiaBuy Lupin Ltd. at a price target of Rs 1470.0 and a stoploss at Rs 1400.0 from entry point21 Apr, 2017, 12.53 PM IST
- Lupin appoints Thierry Volle as President of EMEA businessDrug major Lupin has appointed Thierry Volle as President of Europe, the Middle-East & Africa (EMEA) with immediate effect based at the com...05 Nov, 2015, 07.46 PM IST
Load More
